Thermo Fisher monitoring service for ULT freezers
December 2020—Thermo Fisher Scientific introduced a service designed to enable its team of technical experts to monitor Wi-Fi-connected Thermo Scientific TSX series ultra-low temperature freezers.
Webinars and Sponsored Roundtables — Register Now
Thursday, May 28, 2026, 1:00–2:00 PM ET
This session is designed to improve understanding and application of recent updates to synoptic pathology reporting protocols such as the latest Reporting Template for Reporting Results of Biomarker Testing of Specimens from Patients with Carcinoma of the Breast. These changes reflect evolving clinical guidelines that directly influence diagnostic accuracy and treatment selection in breast cancer care.
Webinar presenters Thaer Khoury, MD, FCAP, Chair, Pathology and Laboratory Medicine, Roswell Park Comprehensive Cancer Cente, and Colin Murphy, CEO of mTuitive.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Wednesday, June 24, 2026, 12:00–1:00 PM ET
Hear an expert discuss the expanded clinical utility of HER2 IHC scoring in metastatic breast cancer and its impact on your practice
Webinar presenters Michelle Shiller, DO, AP, CP, MGP, FACP, Baylor University Medical Center.
Moderated by: Bob McGonnagle, Publisher, CAP TODAY
Subspecialties
Interactive Product Guides
Marketplace Directory
PCR Biosystems kit for Illumina NGS systems
December 2020—PCR Biosystems has introduced its NGSBIO Library Quant Kit for Illumina. The kit contains all the components necessary for accurate and sensitive quantification of DNA libraries prior to next-generation sequencing with Illumina platforms. The kit contains five DNA standards, primers specific to the p5 and p7 Illumina adapter sequences, a library dilution buffer, and qPCRBIO SyGreen Mix or qPCRBIO SyGreen Blue Mix. The blue qPCR mix contains a nonreactive dye to improve reaction mix visibility and is useful when using small reaction volumes or white plates.
Qiagen launches NeuMoDx multiplex test
December 2020—Qiagen announced the European launch of the NeuMoDx Flu A-B/RSV/SARS-CoV-2 Vantage Test, which aims to help health care professionals identify and differentiate between patients with common seasonal respiratory infections and COVID-19. The multiplex PCR test detects and differentiates influenzas A and B, respiratory syncytial virus, and SARS-CoV-2 infections within 80 minutes.
Fabric Genomics launches GEM algorithm for genetic disease dx
December 2020—Fabric Genomics launched Fabric GEM, a novel algorithm that identifies the likely genetic cause of rare diseases using next-generation sequencing.
Eppendorf adjustable spacing pipettes
December 2020—Eppendorf released its Move It Adjustable Spacing Pipettes. Move It was designed for the synchronous pipetting of a series of samples between different vessel formats, such as between tubes and plates, without tubing connections between cone and piston-cylinder system. The format of microplates can be adjusted directly with the format limiters. For other sample tubes or tubes in holders, the cone spacing is selected by using the rotary knob.
SARS-CoV-2 assay for BD Veritor Plus gets CE mark
December 2020—BD announced its rapid, point-of-care, SARS-CoV-2 antigen test for use on the BD Veritor Plus system has been CE marked to the IVD directive. The test delivers results in 15 minutes and has been authorized by the FDA under an EUA for use by authorized laboratories.
Agena granted EUA for SARS-CoV-2 panel
December 2020—Agena Bioscience’s MassArray SARS-CoV-2 Panel for qualitative detection of the SARS-CoV-2 coronavirus has been granted emergency use authorization from the FDA.
FDA approves liquid biopsy NGS CDx
December 2020—The FDA approved the Guardant360 CDx assay (Guardant Health), a liquid biopsy companion diagnostic that also uses next-generation sequencing technology to identify patients with specific types of mutations of the epidermal growth factor receptor gene in a deadly form of metastatic non-small cell lung cancer. This is the first approval to combine NGS and liquid biopsy in one diagnostic test in order to guide treatment decisions.
FDA issues EUA for saline oral rinse COVID-19 test
December 2020—OralDNA Labs announced that the FDA issued an amended emergency use authorization for the OraRisk COVID-19 RT-PCR test, allowing testing from a saline oral rinse collection. Samples are viable for up to 72 hours and do not require cold pack transportation.
Genalyte rapid COVID-19 antibody test obtains EUA
December 2020—Genalyte announced that its SARS-CoV-2 Multi-Antigen Serology Panel received emergency use authorization from the FDA. The panel tests for IgM and IgG antibodies against 13 unique viral antigens and runs on the company’s Maverick diagnostic system, which provides results in 20 minutes. The test demonstrated 98 percent specificity and 96 percent sensitivity.